Kareem A Mohamed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kareem A Mohamed has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed Hanfy
Internal Medicine, Baystate Medical Center, Springfield, United States, USA
1 shared publication - Amr Alkasir
Internal Medicine, Hartford Hospital, Hartford, United States, USA
1 shared publication - Magdy Abdelhamid
Cairo University
1 shared publication - Mohamed Nasser Elshabrawi
Port Said University, Port Said, Egypt
1 shared publication - Mohammed Saifuddin
Internal Medicine, West Virginia University, Morgantown, United States, USA
1 shared publication - William Perucki
Cardiac Electrophysiology, Hartford Hospital, Hartford, United States, USA
1 shared publication
Latest Publications
- Open Access
- 19 November 2026
- Published by MDPI AG in Preprints.org
From Channelopathy to Cardiomyopathy: How Cardiac Magnetic Resonance Reframes Inherited Arrhythmias
Inherited arrhythmia syndromes have traditionally been classified as either primary electrical disorders or structural cardiomyopathies, a framework that increasingly fails to capture the tissue-level abnormalities identified across this spectrum. Cardiac magnetic resonance (CMR) imaging has emerged as a pivotal tool in reframing this paradigm by combining precise ventricular phenotyping with myocardial tissue characterization. In classic channelopathies such as long QT syndrome and catecholaminergic polymorphic ventricular tachycardia, CMR remains primarily exclusionary, while in structural diseases such as arrhythmogenic and hypertrophic cardiomyopathy, it directly identifies the arrhythmogenic substrate through late gadolinium enhancement and parametric mapping. Brugada syndrome occupies an intermediate position, with emerging evidence of subtle right ventricular outflow tract abnormalities challenging its classification as a purely electrical disorder. This review examines the disease-specific diagnostic yield of CMR, its expanding role in risk stratification and implantable cardioverter-defibrillator decision-making, and future directions including artificial intelligence-driven analysis and genotype-phenotype correlation.
- 19 November 2026
- Published by MDPI AG in Preprints.org
Open AccessFrom Channelopathy to Cardiomyopathy: How Cardiac Magnetic Resonance Reframes Inherited Arrhythmias
Inherited arrhythmia syndromes have traditionally been classified as either primary electrical disorders or structural cardiomyopathies, a framework that increasingly fails to capture the tissue-level abnormalities identified across this spectrum. Cardiac magnetic resonance (CMR) imaging has emerged as a pivotal tool in reframing this paradigm by combining precise ventricular phenotyping with myocardial tissue characterization. In classic channelopathies such as long QT syndrome and catecholaminergic polymorphic ventricular tachycardia, CMR remains primarily exclusionary, while in structural diseases such as arrhythmogenic and hypertrophic cardiomyopathy, it directly identifies the arrhythmogenic substrate through late gadolinium enhancement and parametric mapping. Brugada syndrome occupies an intermediate position, with emerging evidence of subtle right ventricular outflow tract abnormalities challenging its classification as a purely electrical disorder. This review examines the disease-specific diagnostic yield of CMR, its expanding role in risk stratification and implantable cardioverter-defibrillator decision-making, and future directions including artificial intelligence-driven analysis and genotype-phenotype correlation.